XT
OGEN icon

XTX Topco’s Oragenics OGEN Stock Holding History

XTX Topco’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,747
Closed -$26.4K – 4211
2025
Q4 		$26.4K Buy
+33,747
New +$36.6K ﹤0.01% 2998
2025
Q2 		– Sell
-828
Closed -$5.22K – 2940
2025
Q1 		$5.22K Sell
828
-470
-36% -$4.06K ﹤0.01% 2306
2024
Q4 		$14.4K Buy
+1,298
New +$13.3K ﹤0.01% 2095

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return

XTX Topco's OGEN Position: Q1 2026 in Review

XTX Topco sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 33,747 shares — an estimated $26.4K sold.

XTX Topco first reported a position in OGEN in Q4 2024 and held it in 3 quarters. The position peaked at $26.4K in Q4 2025. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • XTX Topco reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 33,747 Oragenics shares in Q1 2026, an estimated $26.4K.
  • XTX Topco first reported a position in Oragenics in Q4 2024 and held it in 3 quarters.
  • XTX Topco's Oragenics position peaked at $26.4K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.